-+ 0.00%
-+ 0.00%
-+ 0.00%

MOLECULIN BIOTECH COMPLETES ENROLLMENT IN PART A OF PHASE 2/3 R/R AML MIRACLE TRIAL, KEEPING PROGRAM ON TRACK FOR Q1 2027 DATA READOUT

Reuters·09/29/2026 12:47:18